ImmuCell Corporation (NASDAQ/ICCC)
2005 Interview with: Michael F. Brigham, President and CEO
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their proprietary products that improve animal health and productivity in the dairy and beef industries.

Cover Story

CEOCFO Current Issue

Cover Story Archives

Private Equity Review

CEOCFO Interview Index

Future Features

Analyst Interviews

Corporate Financials

Contact & Ordering

This is a printer friendly page!

ImmuCell is a public biotechnology company dedicated to marketing products that improve animal health and productivity in the dairy and beef industries

ImmuCell

Healthcare
(NASDAQ/ICCC)

ImmuCell Corporation


Michael F. Brigham
President and CEO

Interview conducted by:
Lynn Fosse, Senior Editor
CEOCFOinterviews.com
April 7, 2005

To order the complete April 7, 2005 Issue of CEOCFOinterviews.com left click below for our secure forms:

Purchase NOW!

There is a $5.00 charge for each current issue!
You will be emailed your Current Issue and an invoice for Credit Card payment!

disclaimers

Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews.com is prohibited.

"We started working on a product called Mast Out in 2000. We are very excited and fortunate that by the end of 2004, we brought the technology to a stage where it interested Pfizer and they teamed up with us to take it further. With our Pfizer deal, virtually overnight, the opportunity went from what ImmuCell had as a USFDA effort to a worldwide global effort. Pfizer’s resources can help us expand the program to outside of the US, principally Europe and other territories around the world." - Michael F. Brigham

Newsflash!

To view Releases highlight & left click on the company name!